Lidocaine /ml

PreclinicalSmall molecule

UUniversity Health Network, Toronto

Lidocaine /ml is one of 14 small molecule programs targeting Tinnitus. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

TinnitusActive, not recruiting

AcupunctureCompleted

TinnitusPreclinical

Active, not recruiting

AcupuncturePreclinical

Completed

Competition

Competitive Landscape

14 competitors in Tinnitus

#DrugCompanyPhaseTrials

Levitra

Bayer

Approved

—2

Paxil

SSebela Pharmaceuticals Development LLC

Approved

1 3

Decadron

AAspen Global Incorporated

Approved

1 4

Xylocaine

Rayos

1 6

Pletal

Otsuka

Preclinical

1 7

IV Lidocaine

WWake Forest University Health Sciences

Phase 1

1 8

Syntocinon

SShana McCormack, MD

Preclinical

1 9

Nicorette

HHALEON

Preclinical

2 10

Piribedil

Roche

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2027

Phase 3Active, not recruiting

Post-Mastectomy Pain Syndrome

NCT04874038

Q1 2029

N/ARecruiting

Local Anesthetic

NCT06602349

Clinical

Trials by Indication[1]

Tinnitus1 trial

Action of Intra-auricular Topical Lidocaine on Tinnitus

Completed·UUniversity of Sao Paulo General Hospital·N/A·NCT05711641·32 enrolled

Local Anesthetic1 trial

EFFICACY of USUAL MANAGEMENT of CHRONIC IDIOPATHIC ANO-PERINEAL PAIN by USING LOCAL ANESTHETIC INFILTRATION

Recruiting·GGroupe Hospitalier Diaconesses Croix Saint-Simon·N/A·NCT06602349·60 enrolled

Acupuncture1 trial

Acupuncture for Pain Relief During Perineal Repair After Childbirth

Completed·SSonderborg Hospital·N/A·NCT00328796·207 enrolled

Chronic Post-surgical Pain1 trial

Intravenous Lidocaine in Carcinologic ENT Surgery: A Trial for Evaluation of Opioid Saving Strategy and Chronic Post-surgical Pain (ELICO)

Completed·HHospices Civils de Lyon·Phase 3·NCT02894710·143 enrolled

Analgesia1 trial

Impact of Intra- and Postoperative Continuous Infusion of Lidocaine on Analgesia in Vascular Anaesthesia

Completed·ŁŁukasz Krzych·Phase 4·NCT04691726·87 enrolled

2 more indications

Stroke1 trial

The Role of Peripheral Afferents in Modulating Post-stroke Central Pain

Completed·IInstitut National de la Santé Et de la Recherche Médicale, France·Phase 3·NCT06446960·33 enrolled

Post-mastectomy Pain Syndrome1 trial

Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)

Active, not recruiting·UUniversity Health Network, Toronto·Phase 3·NCT04874038·1,604 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for Lidocaine /ml. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Lidocaine /ml compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Lidocaine /ml. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Health Network, Toronto company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity Health Network, Toronto

Lidocaine /ml

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2027

Q1 2029

Trials by Indication[1]

Tinnitus1 trial

Local Anesthetic1 trial

Acupuncture1 trial

Chronic Post-surgical Pain1 trial

Analgesia1 trial

Stroke1 trial

Post-mastectomy Pain Syndrome1 trial

References

Drug Info

Quick Facts

Related News